Company Financials
AlloVir, Inc. Financials
United States dollar
business
AlloVir, Inc. Company Profile
Main Stock Listing
NASDAQ: ALVR
Market Capitalization $49.5 Million as of July 1, 2025
Market Cap History
Valuations Metrics as of May. 5, 2024
| Trailing PE | |
| Forward PE | -2.66 |
| Price to Sales TTM | $ |
| Price to Book MRQ | $0.61 |
| Enterprise to Revenue | |
| Enterprise to EBITDA | 0.37 |
Financial Reports as of Dec. 31, 2023
Financials
| Fiscal Year Ends | 2023-12-31 |
| Most Recent Quarter | 2023-12-31 |
| Profit Margin | 0.00% |
| Operating Margin | 0.00% |
| Return on Assets TTM | -48.44% |
| Return on Equity TTM | -102.85% |
Income Statement
| Revenue TTM | $0 |
| Revenue per Share TTM | $ |
| Quarterly Revenue Growth | % |
| Gross Profit TTM | $0 |
| EBITDA | $-180,932,992 |
| Net Income to Common TTM | $-190,418,000 |
| Diluted EPS TTM | $-1.83 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | $183,943,008 |
| Total Cash per Share MRQ | $1.65 |
| Total Debt MRQ | $ |
| Total Debt to Equity MRQ | 18.82 |
| Current Ratio MRQ | 6.62 |
| Book Value per Share MRQ | $1.32 |
Cash Flow
| Operating Cash Flow TTM | $-124,451,000 |
| Levered Free Cash Flow TTM | $-66,176,876 |
ALVR Stock Info as of May. 5, 2024
Stock Statistics
| Shares Outstanding | 114,913,000 |
| Float Shares | 38,223,437 |
| Avg 10 Volume | 225,453 |
| Avg 30 Volume | None |
| Shares Short | 6,400,559 |
| Short Ratio | 9.74 |
| Short % of Shares | 10.35% |
| % Held by Insiders | 48.58% |
| % Held by Institutions | 42.74% |
Stock Price Summary
| Beta | 0.85 |
| Fifty Two Week Low | $0.62 |
| Fifty Two Week High | $6.12 |
| Fifty Two Week Change | -447.62% |
| Day 50 MA | $0.75 |
| Day 200 MA | $1.60 |
Dividends and Splits
| Forward Annual Dividend Rate | $ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | $0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |